Karyopharm Therapeutics Inc. (KPTI) has 312 open-market insider trades by 28 insiders since 2013. Over the last six months insiders net sold $41K. The most active filer is Sharon Shacham, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Marcin Czernik | 10% Owner | — | 16 | $31.6M | 2019-02-28 |
| Andreas Hadjimichael | 10% Owner | — | 11 | $30.3M | 2019-02-27 |
| Deepika Pakianathan | Dir | — | 6 | $19.3M | 2026-05-21 |
| Wiaczeslaw Smolokowski | 10% Owner | — | 4 | $17.2M | 2018-07-25 |
| Sharon Shacham | CSO | — | 50 | $14.8M | 2022-03-29 |
| Michael Kauffman | Dir | — | 50 | $14.8M | 2022-02-28 |
| Amalia Hadjimichael | 10% | — | 5 | $13.2M | 2014-12-01 |
| George Hadjimichael | 10% Owner | — | 4 | $6.5M | 2018-09-04 |
| Chione Ltd | 10% Owner | — | 6 | $6.0M | 2018-08-29 |
| Christopher Brett Primiano | VPSecretary | — | 14 | $5.3M | 2020-12-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Kristin Abate | CAO | Sell | $450 | 2026-10-01 |
| Kristin Abate | CAO | Sell | $38 | 2026-09-01 |
| Stuart Poulton | VP | Sell | $1K | 2026-07-28 |
| Reshma Rangwala | VP | Sell | $4K | 2026-05-14 |
| Stuart Poulton | VP | Sell | $4K | 2026-05-14 |
| Sohanya Roshan Cheng | CCO & VP | Sell | $3K | 2026-05-14 |
Companies that share insiders with KPTI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Richard A. Paulson | CEO & President | Sell | $21K | 2026-05-14 |
| Kristin Abate | CAO | Sell | $504 | 2026-05-14 |
| Michael Mano | CLO & VP +1 | Sell | $3K | 2026-05-14 |
| Reshma Rangwala | VP | Sell | $4K | 2026-04-21 |
| Sohanya Roshan Cheng | EVP & Chief Commercial Officer | Sell | $43K | 2026-03-02 |
| Kristin Abate | Chief Accounting Officer | Sell | $5K | 2026-03-02 |
| Richard A. Paulson | President | Sell | $116K | 2026-03-02 |
| Reshma Rangwala | EVP & Chief Medical Officer | Sell | $48K | 2026-03-02 |
| Stuart Poulton | EVP & Chief Development Officer | Sell | $48K | 2026-03-02 |